Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? <i>A Comprehensive Review of Basic Science and Clinical Data</i>

Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? <i>A Comprehensive Review of Basic Science and Clinical Data</i>

Coronary artery disease (CAD) remains one of the most important causes of morbidity and mortality worldwide, and revascularization through percutaneous coronary interventions (PCI) significantly improves survival. In this setting, poor glycaemic control, regardless of diabetes, has been associated w...

Full description

Bibliographic Details
Main Authors: Annunziata Nusca, Francesco Piccirillo, Federico Bernardini, Aurelio De Filippis, Federica Coletti, Fabio Mangiacapra, Elisabetta Ricottini, Rosetta Melfi, Paolo Gallo, Valeria Cammalleri, Nicola Napoli, Gian Paolo Ussia, Francesco Grigioni
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:International Journal of Molecular Sciences
Subjects:
glycaemic control
hyperglycaemia
glycaemic variability
diabetes mellitus
coronary artery disease
percutaneous coronary intervention
Online Access:https://www.mdpi.com/1422-0067/23/13/7261

Internet

https://www.mdpi.com/1422-0067/23/13/7261

Similar Items